Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2022 financial calendar:
- March 24, 2022: Publication of 2021 financial statements
- May 10, 2022: Publication of revenue for 1Q2022
- May 20, 2022: Annual General Shareholders Meeting
- September 15, 2022: Publication of half year financial statements
- November 14, 2022: Publication of revenue for 3Q2022
All financial reports are released before market open CET.
All corporate information, such as the Company’s financial statements and corporate presentations, is available on https://investors.innate-pharma.com.
| Press Release in English | 126.77 KB |
| Communiqué en français | 131.53 KB |